Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Temporarily pausedNCT06169280
What this trial is testing

Repeated Neural Stem Cell Based Virotherapy for Newly Diagnosed High Grade Glioma

Who this might be right for
Glioma, MalignantNew Diagnosis Tumor
Northwestern University 20
Testing effectiveness (Phase 2)Study completedNCT04079296
What this trial is testing

A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome
Astellas Pharma Global Development, Inc. 43
Testing effectiveness (Phase 2)Looking for participantsNCT06798558
What this trial is testing

Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy

Who this might be right for
Prostate Adenocarcinoma
Hackensack Meridian Health 54
Not applicableStudy completedNCT02263378
What this trial is testing

A New Supplement for the Immune Response to HPV Infection

Who this might be right for
HPV Infection
University of Messina 60
Not applicableStudy completedNCT03693378
What this trial is testing

IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups

Who this might be right for
Pancreatic Ductal AdenocarcinomaFamilial Pancreatic CancerFAMMM - Familial Atypical Mole Malignant Melanoma Syndrome
Immunovia, Inc. 1,349
Large-scale testing (Phase 3)WithdrawnNCT03488810
What this trial is testing

Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Active Not RecruitingNCT02960555
What this trial is testing

Isatuximab With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR)

Who this might be right for
Smoldering Plasma Cell Myeloma
M.D. Anderson Cancer Center 61
Not applicableLooking for participantsNCT05889585
What this trial is testing

Morbidity, Long-term Side Effects and Quality of Life in Germ-cell Tumor Long Survivors Treated with High-dose Chemotherapy and Autologous Stem Cell Transplant

Who this might be right for
Germ Cell Tumor
Gustave Roussy, Cancer Campus, Grand Paris 180
Not applicableStudy completedNCT00002485
What this trial is testing

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
Children's Oncology Group 359
Not applicableUnknownNCT06334458
What this trial is testing

Epigenomic and Machine Learning Models to Predict Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
European Institute of Oncology 170
Not applicableUnknownNCT02966574
What this trial is testing

Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers

Who this might be right for
Metastatic Breastcancer
Brugmann University Hospital 50
Not applicableLooking for participantsNCT07062016
What this trial is testing

Molecular and ctDNA Characterization of High-Risk Endometrial Cancer

Who this might be right for
Endometrial CarcinomaEndometrial High Grade Endometrioid AdenocarcinomaStage II Endometrial Cancer+2 more
Mayo Clinic 100
Testing effectiveness (Phase 2)UnknownNCT04582604
What this trial is testing

Ruxolitinib and Decitabine for High Risk Hematological Malignancies

Who this might be right for
Peripheral Blood Stem Cell Transplantation
Chinese PLA General Hospital 60
Early research (Phase 1)Study completedNCT04047004
What this trial is testing

Adjuvant PIPAC in Gastric Cancer Patients

Who this might be right for
Gastric AdenocarcinomaGastric Cancer
Michael Bau Mortensen 20
Large-scale testing (Phase 3)Looking for participantsNCT07720284
What this trial is testing

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Who this might be right for
High-risk Muscle Invasive Urothelial Carcinoma
AstraZeneca 915
Testing effectiveness (Phase 2)Active Not RecruitingNCT03236428
What this trial is testing

Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma

Who this might be right for
Monoclonal GammopathySmoldering Multiple Myeloma
Dana-Farber Cancer Institute 42
Not applicableActive Not RecruitingNCT05657249
What this trial is testing

Alternative Surveillance Program for Patients With High Risk Group of HCC

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 199
Testing effectiveness (Phase 2)Active Not RecruitingNCT03449108
What this trial is testing

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

Who this might be right for
Bone SarcomaDedifferentiated ChondrosarcomaGiant Cell Tumor of Bone+13 more
M.D. Anderson Cancer Center 30
Not applicableNot Yet RecruitingNCT07793240
What this trial is testing

Circulating Tumor DNA (ctDNA) in High Grade Upper Tract Urothelial Cancer (UTUC)

Who this might be right for
Upper Tract Urothelial Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Testing effectiveness (Phase 2)Looking for participantsNCT03753243
What this trial is testing

Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Mark Garzotto, MD 32
Next Page